Changes in Pathological Complete Response Rates after Neoadjuvant Chemotherapy for Breast Carcinoma over Five Years

Historically, neoadjuvant chemotherapy (NACT) was extrapolated from adjuvant regimens. Dual HER2 blockade and the introduction of carboplatin for triple negative breast cancers (TNBC) emerged by December 2013 and have improved pathological complete response (pCR) rates. The objective of this study w...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Oncol
Auteurs principaux: McFarland, Daniel C., Naikan, Jessica, Rozenblit, Mariya, Mandeli, John, Bleiweiss, Ira, Tiersten, Amy
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2016
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4921638/
https://ncbi.nlm.nih.gov/pubmed/27382369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/4324863
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires